TCH (chemotherapy)
TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer.
References
 | This oncology article is a stub. You can help Wikipedia by expanding it. |
This is an old revision of this page, as edited by Ozzie10aaaa (talk | contribs) at 10:12, 22 June 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
TCH is a chemotherapy regimen consisting of Taxotere (docetaxel), carboplatin and Herceptin (trastuzumab), which is used to treat breast cancer.